Bausch Health Companies Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bausch Health Companies Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2024.
  • Bausch Health Companies Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $2.28B, a 1.33% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $2.28B +$30M +1.33% Dec 31, 2024 10-K 2025-02-20
Q3 2024 $2.49B +$293M +13.3% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $2.42B +$216M +9.82% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $2.29B +$294M +14.7% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $2.25B +$231M +11.4% Dec 31, 2023 10-K 2025-02-20
Q3 2023 $2.2B +$269M +13.9% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.2B -$77M -3.38% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2B -$252M -11.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.02B -$199M -8.96% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.93B -$287M -12.9% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $2.28B +$5M +0.22% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.25B +$4M +0.18% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.22B -$30M -1.33% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $2.22B -$538M -19.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $2.27B -$490M -17.7% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $2.25B -$576M -20.4% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $2.25B -$579M -20.5% Dec 31, 2020 8-K 2022-05-11
Q3 2020 $2.76B -$370M -11.8% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $2.76B -$296M -9.68% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.82B -$173M -5.77% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.83B -$82M -2.82% Dec 31, 2019 8-K 2021-05-04
Q3 2019 $3.13B +$653M +26.4% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $3.06B +$682M +28.7% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $3B +$889M +42.2% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $2.91B +$912M +45.6% Dec 31, 2018 10-K 2020-02-19
Q3 2018 $2.47B +$248M +11.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.38B +$263M +12.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $2.11B +$111M +5.56% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $2B +$144M +7.75% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $2.23B +$325M +17.1% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $2.11B +$313M +17.4% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $2B +$537M +36.8% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $1.86B +$491M +35.9% Dec 31, 2016 8-K 2018-08-10
Q3 2016 $1.9B +$880M +86.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.8B +$770M +74.8% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $1.46B +$520M +55.3% Mar 31, 2016 10-Q 2016-06-07
Q4 2015 $1.37B +$507M +59% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $1.02B +$533M +109% Sep 30, 2015 10-Q 2015-10-26
Q2 2015 $1.03B +$543M +111% Jun 30, 2015 10-Q 2015-07-28
Q1 2015 $940M +$435M +86.2% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 $859M +$382M +79.9% Dec 31, 2014 10-K 2016-04-29
Q3 2014 $487M +$134M +37.8% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $487M +$364M +295% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $505M +$380M +305% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $478M +$353M +284% Dec 31, 2013 10-K 2015-02-25
Q3 2013 $354M +$223M +172% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 $123M -$6.8M -5.22% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $125M -$5.7M -4.38% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $125M -$4.23M -3.28% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $130M -$56.7M -30.3% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 $130M -$57.6M -30.7% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 $130M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $129M -$57.7M -30.9% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $187M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $188M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $186M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.